Literature DB >> 34698926

Level 2a evidence comparing robotic versus laparoscopic left lateral hepatic sectionectomy: a meta-analysis.

Shahin Hajibandeh1, Shahab Hajibandeh2, Alexios Dosis3, Mohammed Kaif Qayum4, Karim Hassan2, Ambareen Kausar5, Thomas Satyadas6.   

Abstract

OBJECTIVES: To evaluate comparative outcomes of robotic and laparoscopic left lateral hepatic sectionectomy (LLS).
METHODS: A systematic search of PubMed, Web of Science, EMBASE and bibliographic reference lists with application of a combination of free text and controlled vocabulary search adapted to thesaurus headings, search operators and limits was conducted. Overall, minor (Clavien-Dindo grade < III) and major (Clavien-Dindo grade > III) postoperative complications, mortality, volume of blood loss, conversion to an open procedure, procedure time, length of hospital stay, cost-effectiveness and R1 resection were the evaluated outcome measures.
RESULTS: Seven comparative observational studies reporting a total of 319 patients of whom 150 underwent robotic LLS and the remaining 169 patients underwent laparoscopic LLS were included. The robotic approach was associated with significantly longer procedure time (MD: 29.40 min, p = 0.01) and higher cost (MD: $4170, p < 0.00001) compared to the laparoscopic approach. There was no significant difference in overall postoperative morbidity (OR: 1.29, p = 0.62), Clavien-Dindo grade < III (OR: 1.65, p = 0.49), Clavien-Dindo grade > III (OR: 1.18, p = 0.85), perioperative mortality (RD: 0.00, p = 1.00), volume of blood loss (MD: 1.96 mls, p = 0.91), conversion to an open procedure (RD: - 0.02, p = 0.46), length of hospital stay (MD: 0.22 day, p = 0.52) or R1 resection (RD:0.00, p = 1.00) between two groups.
CONCLUSIONS: Meta-analysis of the best available evidence (level 2) demonstrated that robotic LLS is associated with significantly longer procedure time and higher cost and similar perioperative outcomes compared to the laparoscopic approach. Future randomised studies are required to evaluate short-term perioperative, long-term oncological and surgeon-centred outcomes.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Hepatic resection; Laparoscopic; Left lateral sectionectomy; Robotic

Mesh:

Year:  2021        PMID: 34698926     DOI: 10.1007/s00423-021-02366-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  5 in total

1.  Robotic versus laparoscopic liver resection: a comparative study from a single center.

Authors:  Young-Dong Yu; Ki-Hun Kim; Dong-Hwan Jung; Jung-Man Namkoong; Sam-Youl Yoon; Sung-Won Jung; Sang-Kyung Lee; Sung-Gyu Lee
Journal:  Langenbecks Arch Surg       Date:  2014-11-04       Impact factor: 3.445

2.  Learning curves in minimally invasive hepatectomy: systematic review and meta-regression analysis.

Authors:  Darren Chua; Nicholas Syn; Ye-Xin Koh; Brian K P Goh
Journal:  Br J Surg       Date:  2021-04-30       Impact factor: 6.939

Review 3.  Clinical efficacy of robot-assisted versus laparoscopic liver resection: a meta analysis.

Authors:  Ruoyu Guan; Yongjun Chen; Kui Yang; Di Ma; Xiaoyong Gong; Baiyong Shen; Chenghong Peng
Journal:  Asian J Surg       Date:  2018-08-28       Impact factor: 2.767

Review 4.  Effectiveness and safety of robotic-assisted versus laparoscopic hepatectomy for liver neoplasms: A meta-analysis of retrospective studies.

Authors:  Lidong Hu; Liang Yao; Xiaofei Li; Penghui Jin; Kehu Yang; Tiankang Guo
Journal:  Asian J Surg       Date:  2017-09-12       Impact factor: 2.767

5.  Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.

Authors:  Lilong Zhang; Qihang Yuan; Yao Xu; Weixing Wang
Journal:  PLoS One       Date:  2020-10-13       Impact factor: 3.240

  5 in total
  1 in total

1.  The Role of ICG in Robot-Assisted Liver Resections.

Authors:  Anne-Sophie Mehdorn; Florian Richter; Katharina Hess; Jan Henrik Beckmann; Jan-Hendrik Egberts; Michael Linecker; Thomas Becker; Felix Braun
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.